Abstract
Indications for regional lymph node dissection in melanoma have evolved over time. Once the decision to proceed with axillary lymph node dissection (ALND) has been made, the goal of the procedure in patients with melanoma is complete resection of all lymph nodes (levels I, II, and III) in the axillary basin, respecting the anatomic relations of the axillary vein, thoracodorsal neurovascular bundle, and long thoracic nerve. Performed properly, ALND offers excellent locoregional disease control with acceptably low morbidity rates. While metastasis to epitrochlear nodes is a rare event, epitrochlear lymph node dissection may similarly be an important component of treatment for melanoma patients.
This is a preview of subscription content, log in via an institution to check access.
References
Amaria RN, Prieto PA, Tetzlaff MT et al (2018) Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Lancet Oncol 19(2):181–193
Balch CM (1990) Axillary lymph node dissection: differences in goals and techniques when treating melanoma and breast cancer. Surgery 108:118–119
Bland KI, Klamer TW, Polk HC et al (1981) Isolated regional lymph node dissection: morbidity, mortality, and economic considerations. Ann Surg 193:372–376
Bold RJ, Mansfield PF, Berger DH et al (1998) Prospective, randomized, double-blind study of prophylactic antibiotics in axillary lymph node dissection. Am J Surg 176:239–243
Bowsher WG, Taylor BA, Hughes LE (1986) Morbidity, mortality and local recurrence following regional node dissection for melanoma. Br J Surg 73:906–908
Coit D, Peters M, Brennan M (1991) A prospective randomized trial of perioperative cefazolin treatment in axillary and groin dissection. Arch Surg 126:1366–1371
Conveney E, Weltz ER, Greengrass R et al (1998) Use of paravertebral block anesthesia in the surgical management of breast cancer: experience in 156 cases. Ann Surg 227:496–501
Faries MB, Thompson JF, Cochran AJ et al (2017) Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med 376(23):2211–2222
Goodenough J, Martin H, Shaaban H (2013) Combined ipsilateral neck and axillary lymphadenectomy for metastatic skin cancers: a case series and surgical tips. J Plast Reconstr Aesthet Surg 66(8):1082–1087
Hill MV, McMahon ML, Stucke RS et al (2017) Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg 265(4):709–714
Hunt JA, Thompson JF, Uren RF et al (1998) Epitrohlear lymph nodes as a site of melanoma metastasis. Ann Surg Oncol 5:248–252
Karakousis CP, Hena MA, Emrich LJ et al (1990) Axillary node dissection in malignant melanoma: results and complications. Surgery 108:10–17
Keung EZ, Ukponmwan EU, Cogdill AP et al (2018) The rationale and emerging use of neoadjuvant immune checkpoint blockade for solid malignancies. Ann Surg Oncol 25(7):1814–1827
Kidner TB, Yoon JL, Faries MB et al (2012) Epitrochlear sentinel lymph nodes in melanoma: interval or independent? Am Surg 78(6):702–705
Lee JS, Hu HM, Edelman AL et al (2017) New persistent opioid use among patients with cancer after curative-intent surgery. J Clin Oncol 35(36):4042–4049
Leiter U, Stadler R, Mauch C et al (2016) Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicenter, randomized, phase 3 trial. Lancet Oncol 17(6). https://doi.org/10.1016/S1470-2045(16)00141-8
Moosman DA (1980) Anatomy of the pectoral nerves and their preservation in modified mastectomy. Am J Surg 139:883–886
Morton DL, Wen DR, Wong JH (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127(4):392–399
Neuss H, Reetz C, Raue W et al (2010) Postoperative surgical complications after radical axillary lymph node dissection in melanoma disease result in increased pain. Int Surg 95(2):166–171
Smith TJ, Sloan GM, Baker AR (1983) Epitrochlear node involvement in melanoma of the upper extremity. Cancer 51:756–760
Starritt EC, Joseph D, McKinnon JG et al (2004) Lymphedema after complete axillary node dissection for melanoma. Assessment using a new, objective definition. Ann Surg 240:866–874
Tanabe KK (1997) Lymphatic mapping and epitrochlear lymph node dissection for melanoma. Surgery 121:102–104
Urist M, Maddox W, Kennedy J et al (1983) Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer 51:2152–2156
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Wong, S.L., Tyler, D.S., Balch, C.M., Thompson, J.F., McMasters, K.M. (2019). Axillary and Epitrochlear Lymph Node Dissection for Melanoma. In: Balch, C., et al. Cutaneous Melanoma. Springer, Cham. https://doi.org/10.1007/978-3-319-46029-1_21-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-46029-1_21-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-46029-1
Online ISBN: 978-3-319-46029-1
eBook Packages: Springer Reference MedicineReference Module Medicine